AGE RevisionSPF50 (Dermalogica, Inc.)
Welcome to the PulseAid listing for the AGE Revision drug offered from Dermalogica, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Dermalogica, Inc. |
NON-PROPRIETARY NAME: | Avobenzone and Octinoxate |
SUBSTANCE NAME: | AVOBENZONE; OCTINOXATE |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | TOPICAL |
DOSAGE FORM: | LOTION |
MARKETING CATEGORY NAME: | OTC MONOGRAPH FINAL |
START MARKETING DATE: | 2014-11-25 |
END MARKETING DATE: | 0000-00-00 |
AGE Revision SPF50 HUMAN OTC DRUG Details:
Item Description | AGE Revision SPF50 from Dermalogica, Inc. |
LABELER NAME: | Dermalogica, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 30; 75(mg/mL; mg/mL) |
START MARKETING DATE: | 2014-11-25 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 68479-006_12bc334e-b1f3-4dea-9140-dcd3ad204deb |
PRODUCT NDC: | 68479-006 |
APPLICATION NUMBER: | part352 |
Other AVOBENZONE; OCTINOXATE Pharmaceutical Manufacturers / Labelers: